Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Interesting comment Bart Hendriks on post linkedin 407 đź‘€
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Post by jopatcloon Oct 31, 2024 3:18pm
40 Views
Post# 36291150

Interesting comment Bart Hendriks on post linkedin 407 đź‘€

Interesting comment Bart Hendriks on post linkedin 407 đź‘€Interesting comment Bart Hendriks on post linkedin ! 

Bart Hendriks • 3rd+

Top Motivational Speaker | Author | CEO & Mentor | Inspiring Growth & Transformative Leadership Advisor
 
Thanks Dr Amine Korchi! Before Elon’s team gets too comfy: Grok needs to be better than a radiologist (backed by tons of clinical evidence). And then... Grok needs to be adopted by radiologists and actually paid for. Adopting AI hasn't exactly been love at first sight in radiology, so let’s see if Elon’s new baby has an easier time getting in the door thanks to its sugar daddy’s name!
 
 
 

Bold move, Elon !

Elon Musk just tweeted that his new AI, Grok, is “already quite accurate” at analyzing radiology exams, and he’s encouraging people to test it out.

Fun fact: Grok thought a breast MRI was a brain scan on its first try !

Musk's “state-of-the-art” language model recently scored a staggering $6 billion in Series B funding. But let’s face it, that’s a pricey misdiagnosis !

This type of overstatement aligns with Silicon Valley's “fake it till you make it” spirit.

Having said that, AI-powered chatbots will undeniably advance in handling medical and radiology cases—it’s just a matter of time and data. As high-quality, high-volume data comes in, I see a future where these tools are reliable enough to assist clinicians and researchers, and maybe even interact directly with patients. But for now ? Let’s just say, we’re not quite there yet !

Good try, Elon ! ;)

Read more about it on Marty Stempniak article on Radiology Business ; link in the comments

radiology AI Grok ElonMusk

Bold move, Elon !

Elon Musk just tweeted that his new AI, Grok, is “already quite accurate” at analyzing radiology exams, and he’s encouraging people to test it out.

Fun fact: Grok thought a breast MRI was a brain scan on its first try !

Musk's “state-of-the-art” language model recently scored a staggering $6 billion in Series B funding. But let’s face it, that’s a pricey misdiagnosis !

This type of overstatement aligns with Silicon Valley's “fake it till you make it” spirit.

Having said that, AI-powered chatbots will undeniably advance in handling medical and radiology cases—it’s just a matter of time and data. As high-quality, high-volume data comes in, I see a future where these tools are reliable enough to assist clinicians and researchers, and maybe even interact directly with patients. But for now ? Let’s just say, we’re not quite there yet !

Good try, Elon ! ;)

Read more about it on Marty Stempniak article on Radiology Business ; link in the comments

radiology AI Grok ElonMusk

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities